Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer

Oncology Reports

Volumn 12, Issue 2, 2004, Pages 347-351

  Hotta, Tsukasa ^a   Kobayashi, Yasuhito ^a   Taniguchi, Katsutoshi ^a   Johata, Kiyofumi ^a   Sahara, Masaki ^a   Watanabe, Takashi ^a   Ochiai, Minoru ^a   Tanimura, Hiroshi ^a   Tsubota, Yukari T ^a  

^a WAKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

Dihydropyrimidine dehydrogenase; HCC; Liver metastasis; Thymidine phosphorylase

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDINE PHOSPHORYLASE;

AGED; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NEOPLASM; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS; THYMIDINE PHOSPHORYLASE;

EID: 16544363876     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.2.347     Document Type: Article

References (29)

1. Collie-Duguid ESR, Johnston SJ, Boyce L, Smith N, Cowleson A, Cassidy J, Murray GI and McLeod HL: Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer. Int J Cancer 94: 297-301, 2001. (Pubitemid 32911427)
2. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T and Ishitsuka H: Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411, 1996. (Pubitemid 26403242)
3. Nishimura G, Terada I, Kobayashi T, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Kayahara M, Shimizu K, Ohta T and Miwa K: Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy. Oncol Rep 9: 479-482, 2002.
4. Kikuyama S, Inada T, Shimizu K, Miyakiya M and Ogata Y: p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer. Anticancer Res 21: 2149-2154, 2001.
5. Osanai T, Ichikawa W, Takagi Y, Uetake H, Nihei Z and Sugihara K: Expression of pyrimidine nucleoside phosphorylase (PyNPase) in colorectal cancer. Jpn J Clin Oncol 31: 500-505, 2001. (Pubitemid 33039765)
6. Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa K, Chung YS, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y and Manabe T: Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17: 33-38, 2000.
7. Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S and Noguchi Y: Thymidine phosphorylase/ platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer 79: 1145-1150, 1999. (Pubitemid 29087888)
8. Hiroyasu S, Shiraishi M, Samura H, Tokashiki H, Shimoji H, Isa T and Muto Y: Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Clin Oncol 31: 65-68, 2001. (Pubitemid 32293966)
9. Konno S, Takebayashi Y, Aiba M, Akiyama S and Ogawa K: Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett 166: 103-111, 2001. (Pubitemid 32274291)
10. Ishii R, Takiguchi N, Oda K, Koda K and Miyazaki M: Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer. Int J Oncol 19: 717-722, 2001.
11. Kimura H, Konishi K, Nukui T, Kaji M, Maeda K, Yabushita K, Tsuji M and Miwa A: Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. J Surg Oncol 76: 31-36, 2001. (Pubitemid 32128360)
12. Katsumata K, Sumi T, Yamashita S, Takahashi S, Mori M, Baba T, Murohashi T, Nagashima K, Ashizawa T, Yamamoto K, Koyanagi Y and Katoh K: The significance of thymidine phosphorylase expression in colorectal cancer. Oncol Rep 8: 127-130, 2001. (Pubitemid 33758214)
13. Shimada M, Hasegawa H, Rikimaru T, Gion T, Hamatsu T, Yanashita Y, Shirabe K and Sugimachi K: The significance of thymidine phosphorylase activity in hepatocellular carcinoma and chronic diseased livers: a special reference to liver fibrosis and multicentric tumor occurrence. Cancer Lett 148: 165-172, 2000. (Pubitemid 30047104)
14. Ikeguchi M, Sakatani T, Ueda T, Hirooka Y and Kaibara N: Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas. In vivo 15: 265-270, 2001. (Pubitemid 33039980)
15. Guo L, Kuroda N, Toi M, Miyazaki E, Hayashi Y, Enzan H and Jin Y: Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. Oncol Rep 8: 871-876, 2001. (Pubitemid 33758140)
16. Jin-no K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Endo H, Doi T, Mandai K and Ishitsuka H: Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients. Cancer 82: 1260-1267, 1998. (Pubitemid 28155387)
17. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996. (Pubitemid 26116738)
18. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y, Kondo Y and Sowa M: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477-481, 1995.
19. Takebayashi Y, Akiyama S, Yamada K, Akiba S and Aikou T: Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78: 226-231, 1996. (Pubitemid 26234563)
20. Liotta LA, Kleinerman J and Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004, 1974.
21. Macchiarini P, Fontanini G, Hardin MJ, Squartini F and Angeletti CA: Relation of neovascularisation to metastasis of non-small cell lung cancer. Lancet 340: 145-146, 1992.
22. Celis JE and Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 82: 3262-3266, 1985. (Pubitemid 15033163)
23. Ogawa K, Konno S, Takebayashi Y, Miura K, Katsube T, Kajiwara T, Aiba M, Aikou T and Akiyama S: Clinicopathological and prognostic significance of thymidine phosphorylase expression in gastric carcinoma. Anticancer Res 19: 4363-4368, 1999.
24. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M and Kaibara N: The expression of thymidine phosphorylase and its correlation with angiogenesis in gastric adenocarcinoma. Anticancer Res 19: 4001-4006, 1999.
25. Nagata T, Nakamori M, Iwahashi M and Yamaue H: Overexpression of pyrimidine nucleoside phosphorylase enhances the sensitivity to 5′-deoxy-5-fluorouridine in tumour cells in vitro and in vivo, Eur J Cancer 38: 712-717, 2002. (Pubitemid 34251396)
26. Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T and Fukushima M: Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR. Jpn J Cancer Res 93: 1342-1350, 2002. (Pubitemid 36104874)
27. Zhou J, Tang ZY, Fan J, Wu ZQ, Li XM, Liu YK, Liu F, Sun HC and Ye SL: Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol 126: 57-61, 2000. (Pubitemid 30006353)
28. Luccioni C, Beaumatin J, Bardot V and Lefrançois D: Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts Int J Cancer 58: 517-522, 1994. (Pubitemid 24268092)
29. Johnston SJ, Ridge SA, Cassidy J and McLeod HL: Regulation of dihydropyrimidine dehydrogenase in colorectal cancer. Clin Cancer Res 5: 2566-2570, 1999. (Pubitemid 29437343)